• OTS
  • July 5, 2020
SHARE
Post Views: 496

Buss CG, Bhatia SN.

Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13428-13436.

Pubmed

Related articles

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.

August 5th, 2020
Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists

July 5th, 2020
Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial

Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial

May 15th, 2020
Vaccination against non-mutated neoantigens induced in recurrent and future tumors

Vaccination against non-mutated neoantigens induced in recurrent and future tumors

April 30th, 2020
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses

Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses

February 29th, 2020
Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.

Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.

January 31st, 2020